Evidence map›Paper›PMID 42353213›Full record

ReviewInternational journal of molecular sciences2026

Cellular Models and Functional Assays for Assessing CFTR Function: A Comprehensive Review.

Margarita Lopatina, Anna Demchenko, Svetlana Smirnikhina

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Margarita LopatinaResearch Centre for Medical Genetics, Moskvorechye, 1, 115522 Moscow, Russia.
Anna DemchenkoResearch Centre for Medical Genetics, Moskvorechye, 1, 115522 Moscow, Russia.ORCID 0000-0002-4460-7627
Svetlana SmirnikhinaResearch Centre for Medical Genetics, Moskvorechye, 1, 115522 Moscow, Russia.

Funding

The Ministry of Science and Higher Education of the Russian Federation No
6 · The paper itself

Abstract

Cystic fibrosis (CF) is a genetic disorder caused by dysfunction of the CFTR chloride ion channel. Progress in molecular understanding and therapy development relies on advanced cellular models and robust assays for evaluating CFTR function. This review traces the evolution of in vitro models, from primary and immortalized cell lines to patient-specific induced pluripotent stem cells (iPSCs) and complex three-dimensional systems. These advanced models, including air-liquid interface (ALI) cultures, organoids, and microfluidic organ-on-a-chip platforms, enable recapitulation of tissue architecture, cellular heterogeneity, and key pathological features such as impaired mucociliary clearance and chronic inflammation. A critical component of CF research is the accurate functional assessment of CFTR activity. We compare established high-resolution techniques (patch-clamp, Ussing chamber) with high-throughput screening assays, including fluorescence quenching of halide-sensitive YFP assay and organoid swelling tests. The article provides a framework for choosing the most appropriate CFTR functional assay tailored to specific research goals.

Indexed as

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorModels, BiologicalAnimalsHumansInduced Pluripotent Stem CellsOrganoidsCFTR protein, humanCystic Fibrosis Transmembrane Conductance Regulatorcellular modelCFTRcystic fibrosisfunctional assay

Identifiers

PMID42353213
PMCPMC13299424

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.